Section one: Contracting authority
one.1) Name and addresses
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Nobel House, 17 Smith Square
London
SW1P 3JR
Contact
Chantal Jockel
Country
United Kingdom
Region code
UKI32 - Westminster
Internet address(es)
Main address
https://www.gov.uk/government/organisations/uk-health-security-agency
Buyer's address
https://www.gov.uk/government/organisations/uk-health-security-agency
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Herpes zoster (shingles) vaccine (recombinant, adjuvanted)
Reference number
CM/PHV/23/25156
two.1.2) Main CPV code
- 33651600 - Vaccines
two.1.3) Type of contract
Supplies
two.1.4) Short description
Contract for the supply of herpes zoster, inactivated vaccine
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £1
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
The provision of a vaccine to protect against Shingles, to be used in the national immunisation programme. Deliveries will be required over the initial term of 3 years and the contract has the option to be extended for up to an additional 12 months.
two.2.5) Award criteria
Quality criterion - Name: Comparison with specification / Weighting: N/A
Quality criterion - Name: Volume and delivery / Weighting: N/A
Quality criterion - Name: Risk to programme delivery / Weighting: N/A
Quality criterion - Name: Risk management and contingency plans / Weighting: N/A
Quality criterion - Name: ITO selection questionnaire / Weighting: N/A
Cost criterion - Name: Vaccine price / Weighting: N/A
two.2.11) Information about options
Options: Yes
Description of options
This contract has the option to be extended for up to an additional 12 months
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The services can be provided only by a particular economic operator for the following reason:
- protection of exclusive rights, including intellectual property rights
Explanation:
The Contracting Authority used the negotiated procedure without prior publication under Regulation 32(2)(b)(iii) – to protect exclusive rights - to purchase a quantity of Shingrix. The JCVI has made a recommendation that Shingrix exclusively be used for the national shingles vaccination programme due to the superiority of the vaccine and DHSC is obliged by law to adopt that recommendation, and the Supplier has global exclusive legal rights to manufacture and distribute Shingrix.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
13 February 2023
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
GLAXOSMITHKLINE UK LIMITED - Vaccines
980 Great West Road, Brentford, Middlesex
Brentford
TW8 9GS
Country
United Kingdom
NUTS code
- UKI - London
National registration number
04310159
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1
Total value of the contract/lot: £1
Section six. Complementary information
six.3) Additional information
The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom